Aktuell 15.04.2024 Erster BOOM Summit war erfolgreich Die Veranstalter des BOOM Summit bezeichnen die Premiere als gelungen. Auf der Basler Gesundheitskonferenz tauschten 500 Fachleute am 10. und 11....
News 15.04.2024 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...
News 10.01.2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 10.05.2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 30.04.2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Webinaire Webinaire sur l’accord de libre-échange entre l’AELE et l’Inde 14.03.2024 11:30–12:30 Швейцария
Success stories 23.04.2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News 30.04.2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Webinar Webinar sull'accordo di libero scambio tra Stati AELS e India 14.03.2024 11:30–12:30 Швейцария
Enregistrements vidéo 14.03.2024 Webinaire sur l’accord de libre-échange entre l’AELE et l’Inde Après 16 ans de négociations, l'accord de libre-échange (ALE) entre l'AELE et l'Inde a été signé le 10 mars 2024.
Registrazioni video 30.04.2024 Webinar sull’accordo di libero scambio tra Stati EFTA e l’India Dopo 16 anni di negoziati, l'Accordo di libero scambio (ALS) tra l'EFTA e l'India è stato firmato il 10 marzo 2024.
News 25.04.2024 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 04.04.2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...